by purvi | Dec 12, 2025 | featured, news and press
< Back to Sanius content Deepening Insight into Vaso-Occlusive Crises in Sickle Cell Disease | Evolving Patterns for AI-Driven Prediction at ASH 2025 As ASH 2025 approaches, we are pleased to share new work that digs deeper into one of the most difficult realities...
by purvi | Nov 12, 2025 | featured, news and press
< Back to Sanius content Rewriting the Pathway I The MHRA’s Rare Therapies Policy Paper, and What This Means for Patients, Evidence, and Market Access With more than 3.5 million people living with rare diseases in the UK, affecting 1 in 17 patients and carers...
by purvi | Oct 2, 2025 | featured, news and press
< Back to Sanius content AI breakthroughs predict painful crises in sickle cell disease before they strike. Millions of patients worldwide living with sickle cell disease (SCD) could soon have the power to anticipate painful vaso-occlusive crises (VOCs) before they...
by purvi | Sep 23, 2025 | featured, news and press
< Back to Sanius content From Winter Beds & Unscheduled Care, to Patient Crisis Predictors I Three Years of Learning in Sickle Cell Care. As we celebrate SCD awareness month, I have been reflecting on our work in actively tracking VOCs for the past 3 years....
by purvi | Aug 7, 2025 | featured, news and press
< Back to Sanius content Beyond the Dataset: Accelerating the Full Value of Innovation in Sickle Cell Disease. Over the past five years we have seen an acceleration of new and innovative therapies in Sickle Cell Disease (SCD). Previously, this condition has...